Nucleus is a new kind of genetic test designed to uncover your risks and help you have healthy kids.
Nucleus has raised $14.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Nucleus's investors include Founders Fund, Quiet Capital, Neo, Seven Seven Six, Shrug Capital.
Nucleus is headquartered in New York, United States.
Nucleus is a new kind of genetic test designed to uncover your risks and help you have healthy kids.
Nucleus is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nucleus — Funding & Investors." VCBacked, January 30, 2025, https://www.vcbacked.co/company/nucleus. Accessed September 3, 2026.
VCBacked. (2025). Nucleus — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/nucleus
{{cite web |title=Nucleus — Funding & Investors |url=https://www.vcbacked.co/company/nucleus |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated